Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Alvotech (ALVO) Research & Development (2021 - 2025)

Alvotech filings provide 5 years of Research & Development readings, the most recent being $328.7 million for Q4 2025.

  • On a quarterly basis, Research & Development rose 291.87% to $328.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $184.2 million, a 160.92% increase, with the full-year FY2025 number at $184.2 million, up 7.52% from a year prior.
  • Research & Development hit $328.7 million in Q4 2025 for Alvotech, up from -$51.6 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $337.6 million in Q4 2021 to a low of -$210.8 million in Q4 2023.
  • Median Research & Development over the past 5 years was -$50.7 million (2025), compared with a mean of -$33.4 million.
  • The widest YoY moves for Research & Development: up 291.87% in 2025, down 99900.0% in 2025.
  • Alvotech's Research & Development stood at $337.6 million in 2021, then plummeted by 153.5% to -$180.6 million in 2022, then dropped by 16.72% to -$210.8 million in 2023, then grew by 18.74% to -$171.3 million in 2024, then soared by 291.87% to $328.7 million in 2025.
  • The last three reported values for Research & Development were $328.7 million (Q4 2025), -$51.6 million (Q3 2025), and -$43.0 million (Q2 2025) per Business Quant data.